CPG 7909 Injection in Melanoma

NCT00070642 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Melanoma

Interventions

DRUG: CPG 7909 Injection
DRUG: dacarbazine
DRUG: Chemotherapy
DRUG: CPG 7909 Injection
DRUG: CPG 7909 Injection

Sponsor

Pfizer